Skip to main content
SpringerLink
Log in

Functional Impairment and Cognition in Bipolar Disorder

  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

Bipolar disorder is a common, chronic and severe mental disorder, affecting approximately 2% of the adult population. Bipolar disorder causes substantial psychosocial morbidity that frequently affects the patient's marriage, children, occupation, and other aspects of the patient's life. Few studies have examined the functional impairment in patients with affective illness. Earlier outcome studies of mania reported favorable long-term outcomes. However, modern outcome studies have found that a majority of bipolar patients evidence high rates of functional impairment. These low reports of functional recovery rates are particularly surprising. The basis for such limited functional recovery is not entirely clear. Factors associated with functional dysfunction include presence of inter-episode symptoms, neuroleptic treatment, lower social economic class, and lower premorbid function. Cognitive dysfunction, a symptom domain of schizophrenia, has been identified as an important measure of outcome in the treatment of schizophrenia. Recently, there has been some suggestion that there may be impaired neuropsychological performance in euthymic patients with recurring mood disorders. Whether impaired neuropsychological performance in associated with the functional impairment in bipolar patients who have achieved syndromal recovery is an intriguing question. The literature on functional impairment and cognition in bipolar disorder is reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  • Angst J: Switch from depression to mania-a record study over decades between 1920 and 1982. Psychopathology 18(2-3):140–54, 1985.

    Google Scholar 

  • Atre-Vaidya N, Taylor MA, Seidenberg M, Reed R, Perrine A, Glick-Oberwise F, Cognitive deficits, psychopathology, and psychosocial functioning in bipolar mood disorder. Neuropsychiatry, Neuropsychology, &; Behavioral Neurology 11(3):120–6, 1998.

    Google Scholar 

  • Bellini L, Gambini O, Palladino F, Scarone S: Neuropsychological assessment of functional central nervous system disorders. I. Hemispheric functioning characteristics in schizophrenia and affective illness. Acta Psychiatrica Scandinavica 78(2):242–6, 1988 Aug.

    Google Scholar 

  • Bratfos O, Haug JO: The course of manic-depressive psychosis: a follow-up investigation of 215 patients. Acta Psychiatr Scand 44:89–112, 1968.

    Google Scholar 

  • Cannon M, Jones P, Gilvarry C, Rifkin L, McKenzie K, Foerster A, Murray RM: Premorbid social functioning in schizophrenia and bipolar disorder: similarities and differences. Am J Psychiatry 154:1544–1550, 1997.

    Google Scholar 

  • Carlson GA, Kotin J, Davenport YM, et al.: Follow-up of 53 bipolar manic-depressive patients. Br J Psychiatry 124:134–139, 1974.

    Google Scholar 

  • Coffman JA, Bornstein RA, Olson SC, Schwarzkopf SB, Nasrallah HA: Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biol Psychiatry 1;27 (11):1188–96, 1990 Jun.

    Google Scholar 

  • Cooke RG, Robb JC, Young LT, Joffee RT: Well-being and functioning in patients with bipolar disorder assessed using the MOS 20-item short form (SF-20). J Affect Disord 39:93–97, 1996.

    Google Scholar 

  • Coryell W, Scheftner W, Keller M, et al.: The enduring psychosocial consequences of mania and depression. Am J Psychiatry 150:720–727, 1993.

    Google Scholar 

  • Dion GL, Tohen M, Anthony WA, et al.: Symptoms and functioning of patients with bipolar disorder six months after hospitalization. Hosp Community Psychiatry 39:652–657, 1988.

    Google Scholar 

  • Gallhofer B, Bauer U, Lis S, Krieger S, Gruppe H: Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs. Eur Neuropsychopharmacol 6(Suppl 2):S13–S20, 1996.

    Google Scholar 

  • Ghaemi SN, Sachs GS: Long-term risperidone treatment in bipolar disorder: 6-month follow up. International Clinical Psychopharmacology 12(6):333–8, 1997 Nov.

    Google Scholar 

  • Gitlin MJ, Swendson J, Heller TL, et al.: Relapse and impairment in bipolar disorder. Am J Psychiatry 152:1635–1640, 1995.

    Google Scholar 

  • Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L: A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry 60:733–740, 1999

    Google Scholar 

  • Goldberg JF, Harrow M, Grossman LS: Course and outcome in bipolar affective disorder: a longitudinal follow-up study. Am J Psychiatry 152:379–384, 1995.

    Google Scholar 

  • Goldberg JF, Harrow M, eds.: Bipolar Disorders. Clinical Course and Outcome. American Psychiatric Press, Inc. 1999, pg. 5

  • Goodnick PJ, Fieve RR: Plasma lithium level and interepisode functioning in bipolar disorder. American Journal of Psychiatry 142(6):761–2, 1985 Jun.

    Google Scholar 

  • Goodwin FK, Jamison KR: Manic-Depressive Illness. New York: Oxford University Press. 1990.

    Google Scholar 

  • Harrow M, Goldberg JF, Grossman LS, et al.: Outcome in manic disorders: a naturalistic follow-up study. Arch Gen Psychiatry 47:665–671, 1990.

    Google Scholar 

  • Harvey PD, Powchick P, Parrella M, White L, Davidson M: Symptom severity and cognitive impairment in chronically hospitalized. geriatric patients with affective disorders. British Journal of Psychiatry 170:369–74, 1997 Apr.

    Google Scholar 

  • Hawkins KA, Mohamed S, Woods SW: Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia? Psychol Med 29(1):1–8, 1999 Jan.

    Google Scholar 

  • Hegarty JD, Baldessarini RJ, Tohen M, Waternaux CM, Oepen G: One hundred years of schizophrenia: A meta-analysis of the outcome literature. Am J Psychiatry 151:1409–1416, 1994.

    Google Scholar 

  • Henry AD, Coster WJ: Predictors of functional outcome among adolescents and young adults with psychotic disorders. American Journal of Occupational Therapy 50(3):171–81, 1996 Mar.

    Google Scholar 

  • Himmelhoch JM, Garfinkel ME: Sources of lithium resistance in mixed mania. Psychopharmacol Bull 22:613–620, 1986.

    Google Scholar 

  • Joffe RT: MacDonald C: Kutcher SP: Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disorder. Journal of Clinical Psychopharmacology 8(6):425–8, 1988 Dec.

    Google Scholar 

  • Keck PE Jr, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, Bourne ML, Haggard P: 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 155:646–652, 1998.

    Google Scholar 

  • Keller MB, Lavori PW, Coryell W, Andreasen NC, Endicott J, Clayton PJ, Klerman GL, Hirschfeld RM: Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. Journal of the American Medical Association 255:3138–3142, 1986.

    Google Scholar 

  • Kraepelin E: Manic-Depressive Insanity (1921). Translated by Barclay RM. Edinburgh, Scotland, Linvingstone. Reprint, New York, Arno Press, 1976.

  • Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L: Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiatr Neuropsychopharmakol 13:156–167, 1980.

    Google Scholar 

  • Laroche I, Hodgins S, Toupin J: [Correlation between symptoms and social adjustment in patients suffering from schizophrenia or major affective disorder]. [French] Canadian Journal of Psychiatry-Revue Canadienne de Psychiatrie 40(1):27–34, 1995 Feb.

    Google Scholar 

  • MacQueen GM, Young LT, Robb JC, Cooke RG, Joffe RT. Levels of functioning and well-being in recovered psychotic versus nonpsychotic mania. J Affect Disord 46:69–72 1997.

    Google Scholar 

  • Mayfield D, Coleman LL: Alcohol use and affective disorder. Dis Nerv Syst 29:467–474, 1968.

    Google Scholar 

  • Meltzer HY, Thompson PA, Lee MA, Ranjan R: Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology 14:27S–33S, 1996.

    Google Scholar 

  • Meltzer HY, McGurk SR: The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25:233–55, 1999.

    Google Scholar 

  • Morrison JR: Bipolar affective disorder and alcoholism. Am J Psychiatry 131:1130–1133, 1974.

    Google Scholar 

  • O'Connell RA, Mayo JA, Flatow L, et al.: Outcome of bipolar disorder on longterm treatment with lithium. Br J psychiatry 159:123–129, 1991.

    Google Scholar 

  • Paradiso S, Lamberty GJ, Garvey MJ, Robinson RG: Cognitive impairment in the euthymic phase of chronic unipolar depression. Journal of Nervous &; Mental Disease 185(12):748–54, 1997 Dec.

    Google Scholar 

  • Purdon SE, Jones BD, Stip E, Labelle A, Addington D, David SR, Breier A, Tollefson GD: Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry 57(3):249-58 200 Mar.

  • Rennie TAC. Prognosis in manic-depressive psychoses. Am J Psychiatry 98:801–814, 1942.

    Google Scholar 

  • Robb JC, Young LT, Cooke RG, Joffe RT: Gender differences in patients with bipolar disorder influence outcome in the medical outcomes survey (SF-20) subscale scores. Journal of Affective Disorders. 49(3):189–93, 1998.

    Google Scholar 

  • Rosen LN, Rosenthal NE, Dunner DL, Fieve RR: Social outcome compared in psychotic and nonpsychotic bipolar I patients. J Nerv Ment Dis 171(5):272–5, 1983 May.

    Google Scholar 

  • Savard RJ, Rey AC, Post RM: Halstead-Reitan Category Test in bipolar and unipolar affective disorders. Relationship to age and phase of illness. Journal of Nervous &; Mental Disease 168(5):297–304, 1980.

    Google Scholar 

  • Sax KW, Strakowski SM, Keck PE Jr, McElroy SL, West SA, Stanton SP: Symptom correlates of attentional improvement following hospitalization for a first episode of affective psychosis. Biol Psychiatry 44(8):784–786, 1998.

    Google Scholar 

  • Segal J, Berk M, Brook S: Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clinical Neuropharmacology 21:176–180, 1998.

    Google Scholar 

  • Sharma T, Mockler D: The cognitive efficacy of atypical antipsychotics in schizophrenia. J Clin Psychopharmacol 18:12S–19S1, 1998.

    Google Scholar 

  • Solomon DA, Ristow WR, Keller MB, Kane JM, Gelenberg AJ, Rosenbaum JF: Serum lithium levels and psychosocial function in patients with bipolar disorder. American Journal of Psychiatry 153(10):1301–7, 1996 Oct.

    Google Scholar 

  • Sonne SC, Brady KT, Morton WA: Substance abuse and bipolar affective disorder. J Nerv Ment Dis 182:349–352, 1994.

    Google Scholar 

  • Strakowski SM, Keck PE Jr, McElroy SL, et al. Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatry 55:49–55, 1988.

    Google Scholar 

  • Tham A, Engelbrektson K, Mathe AA, Johnson L, Olsson E, Aberg-Wistedt A: Impaired neuropsychological performance in euthymic patients with recurring mood disorders. Journal of Clinical Psychiatry 58:26–29, 1997.

    Google Scholar 

  • Tohen M, Hennen J, Zarate CA Jr, Baldessarini RJ, Strakowski SM, Stoll AL, Faedda GL, Suppes T, Gebre-Medhin P, Cohen BM: The McLean First Episode Project: Two-year syndromal and functional recovery in 219 cases of major affective disorders with psychotic features. Am J Psychiatry 157:220–228, 2000.

    Google Scholar 

  • Tohen M, Greenfield SF, Weiss RD, Zarate CA Jr, Vagge LM: The effect of comorbid substance use disorders on the course of bipolar disorder: A review. Harvard Rev Psychiatry 6:133–141, 1998a.

    Google Scholar 

  • Tohen M, Sanger TM, McElroy SL, Tollefson GD, Chengappa R, Daniel D, Petty F, Centorrino F, Wang R, Grundy SL, Greaney MG, Jacobs TG, David SR, Toma V and the olanzapine HGEH study group. Am J Psychiatry 156:702–709, 1999.

    Google Scholar 

  • Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 47:1106–1111, 1990.

    Google Scholar 

  • Tohen M, Zarate CA Jr, Centorrino F, Hegarty J, Froeschl M, Zarate SB: Risperidone in the treatment of mania. J Clin Psychiatry 57:249–253, 1996.

    Google Scholar 

  • Tohen M, Zarate CA Jr: Antipsychotic Drugs in Bipolar Disorder. J Clin Psychiatry 59[suppl 1]:38–48, 1998b.

    Google Scholar 

  • Tsuang MT, Woolson RF, Fleming JA: Long-term outcome of major psychoses; I: schizophrenia and affective disorders compared with psychiatrically symptom-free surgical controls. Arch Gen Psychiatry 39:1295–1301, 1979.

    Google Scholar 

  • van Gorp WG, Altshuler L, Theberge DC, Wilkins J, Dixon W: Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 55:41–6, 1998.

    Google Scholar 

  • Zarate CA Jr, Narendran R, Tohen M, Greaney JJ, Berman A, Pike S, Madrid A. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry 59:24–28, 1998.

    Google Scholar 

  • Zarate CA Jr, Tohen M, Baldessarini RJ: Clozapine in severe mood disorders. J Clin Psychiatry 56:411–417, 1995.

    Google Scholar 

  • Zarate CA Jr, Tohen M: Antipsychotic drug treatment in first-episode mania: a 6-month longitudinal study. J Clin Psychiatry 61:33–38, 2000.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Bipolar and Psychotic Disorders Program, University of Massachusetts Medical School, Worcester, MA

    Carlos A. Zarate Jr.

  2. Harvard Medical School, McLean Hospital, Belmont, MA

    Mauricio Tohen

  3. Lilly Research Laboratories, Indianapolis, IN

    Mauricio Tohen

  4. The Bipolar and Psychotic Disorders Program, University of Massachusetts Medical School, Worcester, MA

    Michelle Land & Sarah Cavanagh

Authors
  1. Carlos A. Zarate Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mauricio Tohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michelle Land
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sarah Cavanagh
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zarate, C.A., Tohen, M., Land, M. et al. Functional Impairment and Cognition in Bipolar Disorder. Psychiatr Q 71, 309–329 (2000). https://doi.org/10.1023/A:1004632206684

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1004632206684

Keywords

Search

Navigation